Published in Am J Hematol on December 01, 2006
Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty. Tex Heart Inst J (2012) 0.82
Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction. Platelets (2009) 0.80
Variability in reexcision following breast conservation surgery. JAMA (2012) 3.26
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg (2013) 2.08
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. Endocrine (2013) 1.42
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev (2012) 1.15
Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care (2014) 1.01
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev (2012) 1.00
Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med (2013) 0.95
Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab. J Vasc Interv Radiol (2008) 0.92
Anti-phospholipid antibodies in patients undergoing total joint replacement surgery. Thrombosis (2012) 0.84
Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma. Clin Nucl Med (2010) 0.83
Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care (2012) 0.82
Methods for the bias adjustment of meta-analyses of published observational studies. J Eval Clin Pract (2012) 0.82
All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol (2015) 0.81
Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort. Clin Med Res (2011) 0.76
The debate over lifesaving benefit of screening mammography continues. Arch Intern Med (2012) 0.75
Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clin Med Res (2013) 0.75
Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. Thromb Res (2013) 0.75
Oesophageal papillomatosis, not amenable to endoscopic therapies, treated with oesophagectomy. BMJ Case Rep (2014) 0.75
Coalition building and the intervention wheel to address breast cancer screening in hmong women. Clin Med Res (2011) 0.75
Peripancreatic cystic lymphangioma diagnosed by endoscopic ultrasound/fine-needle aspiration: a rare mesenchymal tumour. BMJ Case Rep (2013) 0.75
Secondary hormonal manipulations in the management of advanced prostate cancer. Can J Urol (2005) 0.75
Antithrombin levels are unaffected by warfarin use. Arch Pathol Lab Med (2014) 0.75
Recent data regarding low versus high 131I activity for remnant ablation in differentiated thyroid cancer are not generalizable beyond eligibility criteria. Nucl Med Commun (2012) 0.75